CannRx Technology, Inc.

CannRx intends to become a leader in the development of FDA approved medical applications for cannabis.

  • Stage Product In Development
  • Industry Healthcare Services
  • Location New York, NY, US
  • Currency USD
  • Founded 2013
  • Employees 4
  • Website cannrx.com

Company Summary

The goal of CannRx is to develop high-quality pharmaceutical and analytical products utilizing the cannabis plant by leveraging patented technology and established botanical expertise. CannRx intends to develop products that assure consistency and under FDA defined procedures. CannRx has already developed specific validated assays for cannabinoids.

Team

  • Barry Jay
    CEO

    A proven operations leader in the pharma development, management and academic domain with experience in culturing relationships with the pharmaceutical industry, negotiating contracts, writing/implementing research protocols and conducting clinical trials. Dr. Hahn is the author of numerous publications in peer reviewed journals. Dr Hahn has published over 50 peer reviewed papers and has presented at numerous scientific forums.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free